New drug injection shows promise for severe Post-Birth depression in small early trial
NCT ID NCT02285504
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 27 times
Summary
This early study tested an experimental drug called SAGE-547 in 4 women with severe postpartum depression. The main goal was to check if the drug is safe and how the body processes it. Results are limited due to the very small number of participants, but the study helps lay the groundwork for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sage Investigational Site
Chapel Hill, North Carolina, 27514, United States
Conditions
Explore the condition pages connected to this study.